Senior Director, Product Development ,
Marwane Berrada, Senior Director, Product Development at the Cleveland Clinic has been a leader in the field of medical devices for over fifteen (15) years, with extensive experience in medtech product development and commercialization. His current responsibilities include resolving clinical unmet needs for the Heart and Vascular Institute and spinning out projects or companies; Board advisor to companies who have received commercialization funding from the Global Cardiovascular Innovation Center; and Project Director at NCAI-CC (NIH Center for Accelerated Innovations) a pilot program initiated by the NIH to mind the “valley of death” funding and accelerate commercialization.
His product expertise has been in percutaneous therapies such as electrophysiology, structural heart, cardiovascular and endovascular devices, in addition to product commercialization of orthopedic implants. Through his engineering and business backgrounds, Marwane is experienced in leading both traditional and virtual R&D teams throughout the entire development life-cycle including 510k and PMA regulatory tracks. Marwane has held various technical/engineering, managerial, and executive management positions at Boston Scientific, Microvena, ev3 (acquired by Covidien, now Medtronic), CryoCath Technologies (acquired by Medtronic), Bavaria Medical Technologies, Vascular NanoTransfer and OligoMedic. Currently Marwane holds nine patents in medical devices and more than thirteen patent applications. Marwane holds a Bachelor’s and Master’s degree in Mechanical Engineering from the University of Minnesota and an MBA in Finance from McGill University.